These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 1706536)

  • 1. Prenatal screening for open neural tube defects, Down's syndrome, and other major fetal disorders.
    Haddow JE
    Semin Perinatol; 1990 Dec; 14(6):488-503. PubMed ID: 1706536
    [No Abstract]   [Full Text] [Related]  

  • 2. Prenatal biochemical screening for Down's syndrome and neural tube defects.
    Wald NJ; Kennard A
    Curr Opin Obstet Gynecol; 1992 Apr; 4(2):302-7. PubMed ID: 1373963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prenatal serum screening of aneuploidy and of neural tube defects in the second trimester of pregnancy among the population of Luxembourg. Evaluation of risk by the triple test (AFP+THCG+UE3)].
    Thix J
    Bull Soc Sci Med Grand Duche Luxemb; 1997; 134(1):25-9. PubMed ID: 9303823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural tube defects/alpha-fetoprotein/Down's syndrome screening.
    Aitken DA; Crossley JA
    Curr Opin Obstet Gynecol; 1997 Apr; 9(2):113-20. PubMed ID: 9204233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal serum screening for neural tube defects and Down's syndrome.
    Robertson EF
    Med J Aust; 1991 Jul; 155(2):67-8. PubMed ID: 1713290
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening and diagnosis of fetal neural tube defects, abdominal wall defects and Down's syndrome. With special reference to biochemical and ultrasound screening in the second trimester of pregnancy and to early amniocentesis.
    Jørgensen FS
    Dan Med Bull; 2001 Aug; 48(3):127-45. PubMed ID: 11556264
    [No Abstract]   [Full Text] [Related]  

  • 7. Maternal serum screening for neural tube defects and Down's syndrome.
    Robertson EF
    Med J Aust; 1991 Sep; 155(5):349. PubMed ID: 1832734
    [No Abstract]   [Full Text] [Related]  

  • 8. [How women cope with the results of maternal serum screening for fetal neural tube defects and Down syndrome].
    Kamerbeek LI; Roelofsen EE; Beekhuis JR; Tijmstra T; Mantingh A
    Ned Tijdschr Geneeskd; 1993 Jun; 137(26):1308-11. PubMed ID: 7688449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using record linkage and manual follow-up to evaluate the Victorian maternal serum screening quadruple test for Down's syndrome, trisomy 18 and neural tube defects.
    Jaques AM; Collins VR; Haynes K; Sheffield LJ; Francis I; Forbes R; Halliday JL
    J Med Screen; 2006; 13(1):8-13. PubMed ID: 16569299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alpha-1-fetoprotein in the amniotic fluid and blood of pregnant women].
    Zizkovský V; Koubová J; Havranová M; Chudý D; Fuchs V
    Cesk Gynekol; 1988 Jun; 53(5):330-9. PubMed ID: 2457452
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prenatal diagnosis of neural tube defects].
    Agosti S; Brambati B; Cucconi T; Mariani V
    Pediatr Med Chir; 1982; 4(1-2):71-7. PubMed ID: 6180415
    [No Abstract]   [Full Text] [Related]  

  • 12. Maternal serum screening for neural tube defects and Down syndrome.
    Keith D
    Clin Lab Sci; 1992; 5(5):274-6. PubMed ID: 10150964
    [No Abstract]   [Full Text] [Related]  

  • 13. [Serum analysis in pregnant women. Mass screening is an effective way to discover chromosome aberrations--arguments for and against].
    Kristoffersson U; Nørgaard-Pedersen B
    Lakartidningen; 1995 Mar; 92(12):1205-6, 1211-2. PubMed ID: 7535873
    [No Abstract]   [Full Text] [Related]  

  • 14. Insulin-dependent diabetes mellitus and prenatal screening results: current experience from a regional screening programme.
    Crossley JA; Berry E; Aitken DA; Connor JM
    Prenat Diagn; 1996 Nov; 16(11):1039-42. PubMed ID: 8953638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Maternal serum screening for Down syndrome and neural tube defects].
    van Rijn M; Christiaens GC; van der Schouw YT; Hagenaars AM; de Pater JM; Visser GH
    Ned Tijdschr Geneeskd; 1998 Feb; 142(8):409-15. PubMed ID: 9562776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal serum alpha-fetoprotein screening: benefits, risks, and costs.
    Campbell TL
    J Fam Pract; 1987 Nov; 25(5):461-7. PubMed ID: 2445897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal diagnosis of open neural tube defects using the amniotic fluid acetylcholinesterase assay.
    Milunsky A; Sapirstein VS
    Obstet Gynecol; 1982 Jan; 59(1):1-5. PubMed ID: 6176922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for fetal neural tube defects: rationale and experience.
    Brock DJ
    Prog Clin Biol Res; 1982; 103 Pt B():461-72. PubMed ID: 6187021
    [No Abstract]   [Full Text] [Related]  

  • 19. Triploidy identified through second-trimester serum screening.
    Huang T; Alberman E; Wald N; Summers AM
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal screening for open neural tube defects and Down syndrome: three decades of progress.
    Wald NJ
    Prenat Diagn; 2010 Jul; 30(7):619-21. PubMed ID: 20572104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.